Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Four beakers lined up on a table in a lab.

    New Initiative Will Engage Underrepresented Populations in Parkinson’s Research

    Four sites around the U.S. will develop community-focused programs to develop culturally relevant messaging and materials to engage the Parkinson’s community.
    Learn more
  • Funded Research: Dyskinesia Imaging, Telemedicine and Inflammation-Fighting Bacteria

    More Evidence for Inflammation’s Role in Parkinson’s Disease

    New findings shows how a heightened inflammatory response may lead to Parkinson’s and explain why the disease starts outside the brain.
    Learn more
  • Samples in the lab.

    PPMI Dispatch: Early Signs of Disease and Striking Some Potential Markers

    Findings from the Parkinson’s Progression Markers Initiative show subtle symptoms in mutation carriers and that motor subtypes change with time and therapy.
    Learn more
  • Logo for Ken Griffin Alpha-synuclein Imaging Competition.

    MJFF Announces $10-million “Ken Griffin Alpha-synuclein Imaging Competition” to Develop Game-Changing Tool in Parkinson’s

    MJFF launches the “Ken Griffin Alpha-synuclein Imaging Competition,” a $10-million program to spur a scientific race in pursuit of a game-changing tool in Parkinson’s research: an imaging tracer to…
    Learn more
  • Banner for the 2019 International Congress of Parkinson's Disease and Movement Disorders.

    Getting Ready for the International Congress of Parkinson's Disease and Movement Disorders

    Each year, this meeting brings together thousands of clinicians, researchers, and members of industry working on movement disorders such as Parkinson’s.
    Learn more
  • Lab Equipment

    New Drug FDA-Approved for Parkinson’s “Off” Time

    The FDA has approved Nourianz, a new drug that works differently from currently available Parkinson’s medications, to decrease “off” time.
    Learn more
  • Map of Africa, East Asia and India where researchers are expanding genetic research for Parkinson's disease.

    New $5 Million Program Will Explore Parkinson’s Genetics in African, East Asian and Indian Populations

    Projects will analyze samples from more than 30,000 people to better define Parkinson’s genetics and point to new treatments.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.